SBIR/STTR Research Award

One-Step In Situ RNA Integrity Analysis for FFPE Tissue

Award identifier 497147655dbada9b6679f983a3957f9a6030bfd9c150799eab90e9b970ec4da9Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$166,955

Program and phase

SBIR · Phase I

Award year

2011

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
DXTERITY DIAGNOSTICS INCORPORATED
Proposal award date
Not reported
Contract end date
Not reported
UEI
L2MYPKV2PNG3
Solicitation number
PA10-050
Topic code
NHGRI

Research abstract

DESCRIPTION (provided by applicant): A rapid and simple in situ test for RNA integrity in Formalin-Fixed Paraffin Embedded (FFPE) will be developed in order to facilitate the selection of well-annotated, archival FFPE clinical samples with high quality RNAfor gene expression analysis. The ratio of fluorescence signal from Quenched Auto Ligation (QUAL) probes of different lengths will be used to assess the degree of RNA fragmentation in FFPE samples in situ, prior to cumbersome and time- consuming RNA extraction. The Quality Control (QC) metric from the QUAL probes will be correlated to the quality of downstream gene expression analysis by RT-PCR and microarray on RNA extracted from the FFPE samples assayed for RNA integrity. The eventual goal is to developand commercialize a QC kit for FFPE sample RNA quality. This research will aid and accelerate the discovery of more accurate molecular biomarkers for detection, prognosis and treatment of cancer. PUBLIC HEALTH RELEVANCE: One Step In Situ RNA Integrity Analysis for FFPE Tissue . There are millions of potentially valuable, well-annotated clinical pathology samples around the world many of which cannot be used for clinical studies because of poor sample quality. The proposed research will enable more accurate detection, prognosis and treatment of cancer by improving the accuracy of selecting only high quality archival pathology samples for molecular analysis. The development of a simple and rapid, commercially available test to assess the quality of a pathology sample will also accelerate the pace of molecular studies needed for the discovery of drugs for cancer patients, and the detection of cancer in the general population in order to improve public health.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

3 SBIR/STTR records share this UEI (2011–2016). Reported award amounts total $1,945,603. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.